HUB Investment Partners LLC Increases Stock Position in Danaher Co. (NYSE:DHR)

HUB Investment Partners LLC grew its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 241.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,407 shares of the conglomerate's stock after purchasing an additional 2,410 shares during the quarter. HUB Investment Partners LLC's holdings in Danaher were worth $782,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the fourth quarter worth about $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC raised its stake in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is owned by corporate insiders.

Remove Ads

Danaher Price Performance

NYSE:DHR traded down $0.44 during trading hours on Tuesday, reaching $212.36. 3,077,187 shares of the company traded hands, compared to its average volume of 3,016,116. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm's 50-day moving average is $216.92 and its 200-day moving average is $238.13. The stock has a market cap of $151.78 billion, a P/E ratio of 40.22, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the business posted $2.09 earnings per share. Equities research analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. This is a positive change from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio (DPR) is 24.24%.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Wells Fargo & Company lowered their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research report on Friday, March 14th. Barclays dropped their target price on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Jefferies Financial Group reduced their price target on Danaher from $285.00 to $260.00 and set a "buy" rating for the company in a report on Wednesday, January 29th. Finally, Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They set a "buy" rating and a $275.00 price objective on the stock. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and an average target price of $278.24.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.